"Bath salts" are synthetic cathinone derivatives (e.g., MDPV, mephedrone, methylone) that produce a sympathomimetic toxidrome similar to amphetamine/cocaine intoxication, characterized by severe agitation, psychosis, hyperthermia, and cardiovascular toxicity. [1-2] Treatment is primarily supportive with benzodiazepines as first-line therapy. [3-5]
1. History
- Substance used: Ask specifically about "bath salts," "flakka," "cloud nine," "vanilla sky," "ivory wave," or other street names; route of administration (insufflation, oral, IV, smoking, rectal) [1]
- Timing of ingestion, amount, and whether single or repeated dosing; intoxication typically lasts 6–8 hours but can be prolonged [1]
- Coingestions: Extremely common — alcohol, cannabis, amphetamines, opioids; polysubstance use alters the clinical picture [1][6]
- Symptom progression: Euphoria → agitation → paranoia → psychosis → combativeness; ask about hallucinations, suicidal ideation, self-harm [1]
- Prior use history and tolerance; high addictive potential [1]
- Purchase source (gas stations, head shops, internet) — often labeled "not for human consumption" [5]
2. Alarm Features
- Hyperthermia >40°C (104°F) — rapidly life-threatening and the single most dangerous sign [3][7]
- Seizures or status epilepticus [1][7]
- Severe rhabdomyolysis (dark urine, muscle rigidity) [1][5]
- Chest pain or ECG changes suggesting myocardial ischemia/infarction (vasospasm can occur with normal coronaries) [3][7]
- Signs of cardiogenic shock or stress (takotsubo) cardiomyopathy [3][7]
- Cardiac arrest (VF, VT, PEA) [3][7]
- Cerebral edema, stroke [1]
- Sustained physical restraint without adequate sedation — associated with death [3][7]
3. Medications
- First-line: Benzodiazepines (e.g., midazolam 5 mg IV/IM, lorazepam 2–4 mg IV, diazepam 5–10 mg IV) — controls agitation, prevents seizures, reduces hyperthermia and rhabdomyolysis; large doses may be required [3-5][7]
- Second-line for persistent agitation: Antipsychotics (e.g., haloperidol, droperidol) — use with caution given QTc prolongation risk and lowered seizure threshold [2][7]
- Refractory hyperadrenergic state: Dexmedetomidine (severe symptoms) or clonidine (mild-moderate) per ASAM/AAAP guidelines [4][8]
- Hypertensive emergency: Short-acting agents — phentolamine, sodium nitroprusside, dihydropyridine CCBs; avoid long-acting antihypertensives (risk of hemodynamic collapse) [4]
- Coronary vasospasm: Nitroglycerin, CCBs [3][7]
- Contraindicated: Pure beta-blockers (risk of unopposed alpha stimulation); if beta-blockade needed, use labetalol or carvedilol [4][8]
- Ketamine may be considered for refractory agitation [7]
4. Diet
- Not directly applicable in the acute setting
- Aggressive IV hydration is critical — supports renal perfusion, treats rhabdomyolysis, and addresses dehydration from hyperthermia and agitation [2][5]
- NPO if intubated or altered mental status
5. Review of Systems
- Neuro: Headache, seizures, visual/auditory hallucinations, paranoia, suicidal ideation, self-mutilation [1]
- Cardiac: Chest pain, palpitations, dyspnea [1][7]
- Musculoskeletal: Muscle pain, rigidity, dark urine (rhabdomyolysis) [1][5]
- Psych: Panic attacks, anxiety, severe paranoia, psychosis, violent/aggressive behavior [1][6]
- GI: Nausea, vomiting, abdominal pain
- Derm: Diaphoresis, skin picking/excoriations [1]
6. Collateral History and Family History
- Collateral is essential — patients are often too agitated or psychotic to provide reliable history; obtain from EMS, law enforcement, friends, family
- Ask about packaging, product names, or residual substance brought in
- Prior psychiatric history (schizophrenia, bipolar disorder) — synthetic cathinone psychosis can unmask or exacerbate underlying psychiatric illness [6][9]
- History of substance use disorder, prior overdoses, prior ICU admissions [5]
- Family history of cardiac disease (relevant if considering arrhythmia risk)
7. Risk Factors
- Young adults (18–35), predominantly male [5][10]
- Polysubstance use disorder [5-6]
- Pre-existing psychiatric disorders (schizophrenia, bipolar disorder) [5][9]
- Housing instability and homelessness [10]
- Availability via internet and convenience stores despite scheduling [1][5]
- Ethanol and amphetamine co-use may increase cathinone toxicity [11]
8. Differential Diagnosis
- Amphetamine/methamphetamine intoxication — clinically indistinguishable; differentiated only by specific confirmatory testing [9]
- Cocaine toxicity — shorter duration, positive urine immunoassay
- PCP intoxication — similar agitation/psychosis, may have nystagmus and analgesia [9]
- Serotonin syndrome — clonus, hyperreflexia, diarrhea; medication history key
- Neuroleptic malignant syndrome — lead-pipe rigidity, medication exposure
- Anticholinergic toxidrome — dry skin, urinary retention, absent bowel sounds (vs. diaphoresis in sympathomimetics)
- Thyroid storm — goiter, thyroid history
- Meningitis/encephalitis — fever + altered mental status; consider LP if diagnostic uncertainty
- Excited delirium — overlapping entity, often associated with stimulant use
- Primary psychiatric decompensation (acute psychosis, mania) — must rule out toxic etiology first [9][12]
9. Past Medical History
- Prior stimulant use or overdose episodes
- Psychiatric diagnoses (psychosis, bipolar, PTSD)
- Cardiac history (CAD, arrhythmias, cardiomyopathy)
- Renal disease (increased rhabdomyolysis risk)
- Seizure disorder
- Hepatic disease (altered drug metabolism)
- HIV/Hepatitis (if IV use)
10. Physical Exam
- Vitals: Tachycardia, hypertension, hyperthermia, tachypnea — the classic sympathomimetic vital sign pattern [1-2][7]
- Neuro: Agitation, mydriasis, hyperreflexia, tremor, clonus, seizures; assess GCS
- Psych: Paranoia, hallucinations, combativeness, disorganized thought
- Skin: Diaphoresis (distinguishes from anticholinergic), skin excoriations, track marks (if IV use)
- Cardiac: Tachycardia, murmurs (endocarditis if IV user)
- Musculoskeletal: Muscle rigidity, tenderness (rhabdomyolysis)
- Rectal temperature — most accurate for core temperature; axillary/oral unreliable in agitated patients
11. Lab Studies
- BMP/CMP: Electrolytes, renal function (AKI from rhabdomyolysis), glucose, bicarbonate (metabolic acidosis) [2][7]
- CK (creatine kinase): Rhabdomyolysis marker — often markedly elevated [1][5]
- Lactate: Elevated from agitation, hyperthermia, and tissue hypoperfusion
- VBG/ABG: Assess acid-base status
- Troponin: Rule out myocardial injury/infarction [7]
- CBC: Leukocytosis common (stress response)
- Coagulation studies: DIC screening if severe
- LFTs: Hepatic injury in severe cases
- Urinalysis: Myoglobinuria
- Urine drug screen: Will typically be negative — MDPV and most synthetic cathinones are NOT detected on standard immunoassays [1][4][13]
- Confirmatory testing: Gas chromatography–mass spectrometry (GC-MS) or liquid chromatography–tandem mass spectrometry (LC-MS/MS) can identify specific cathinones but results are not available acutely [4][11][13]
12. Imaging
- Chest X-ray: If respiratory distress, aspiration concern, or intubated
- CT head (non-contrast): If seizures, focal neurological deficits, or persistent altered mental status — rule out intracranial hemorrhage, stroke, cerebral edema [1]
- CT angiography: If stroke symptoms
- Echocardiography: If hemodynamic instability or suspected takotsubo cardiomyopathy [3][7]
- Imaging is not routinely necessary in mild-moderate presentations that resolve with sedation
13. Special Tests
- Point-of-care glucose: Immediate — rule out hypoglycemia as cause of altered mental status
- Point-of-care ultrasound (POCUS): Cardiac function assessment, IVC for volume status
- Poison Control / Medical Toxicology consultation — recommended for severe or refractory cases
- Regional drug surveillance data may help identify circulating synthetic cathinones [4]
14. ECG
- Obtain on all patients with bath salts toxicity
- Sinus tachycardia — most common finding [1]
- QTc prolongation — risk of torsades de pointes, especially with antipsychotic co-administration
- ST-segment changes — coronary vasospasm can cause STEMI pattern even with normal coronaries [3][7]
- Wide QRS — sodium channel blockade (some cathinones)
- Dysrhythmias: VT, VF, SVT [1][7]
15. Assessment
Bath salts toxicity presents as a sympathomimetic toxidrome with a spectrum of severity ranging from mild agitation and tachycardia to life-threatening hyperthermia, rhabdomyolysis, seizures, cardiac arrest, and death. [1-2][7] The clinical picture is often indistinguishable from methamphetamine or cocaine intoxication, and the specific agent cannot be identified acutely since standard drug screens are negative. [1][13] Coingestion is the rule rather than the exception. Behavioral manifestations (severe paranoia, psychosis, violent combativeness, self-harm) are often more prominent and prolonged than with other stimulants, and the duration of toxicity (6–8 hours) exceeds that of cocaine. [1][6]
Key complications to anticipate:
- Rhabdomyolysis → AKI
- Hyperthermia → multi-organ failure, DIC
- Coronary vasospasm → MI
- Stress cardiomyopathy (takotsubo) [3][7]
- Intracranial hemorrhage/stroke [1]
16. Treatment Plan
Initial Stabilization
- ABCs; prepare for rapid sequence intubation if unable to protect airway
- Benzodiazepines first-line for agitation, seizures, and sympatholysis — titrate aggressively; large doses often required [3-5][7]
- Active cooling for core temp >40°C: ice water immersion is fastest and preferred; evaporative cooling as alternative [3][7]
- IV crystalloid bolus — aggressive hydration targeting urine output >1–2 mL/kg/hr if rhabdomyolysis [5]
Refractory Agitation
- Add antipsychotics (haloperidol 5–10 mg IM/IV) or ketamine (4 mg/kg IM) [2][7]
- Dexmedetomidine infusion for ICU-level management [4][8]
Cardiovascular
- Nitroglycerin or CCBs for coronary vasospasm/chest pain with ischemic ECG changes [3][7]
- Phentolamine or nitroprusside for hypertensive emergency [4]
- Avoid pure beta-blockers; if needed, use labetalol [4][8]
- VA-ECMO or IABP for refractory cardiogenic shock from takotsubo cardiomyopathy [3][7]
Seizures
- Benzodiazepines first-line; phenobarbital for refractory seizures
- Avoid phenytoin (ineffective in toxicologic seizures and may worsen cardiac conduction)
Physical Restraints
- sustained restraint without adequate sedation is associated with death[3][7]
17. Disposition
- ICU admission: Hyperthermia >40°C, seizures, intubation, rhabdomyolysis with AKI, cardiac ischemia, hemodynamic instability, refractory agitation requiring continuous sedation [5]
- Observation/telemetry: Moderate agitation responding to benzodiazepines, mild tachycardia/hypertension, CK elevation without renal impairment
- Discharge criteria: Resolution of agitation and psychosis, normal vital signs, normal mental status, normal renal function, downtrending CK, psychiatric safety assessment completed, no suicidal ideation [5]
- Psychiatry consultation: For persistent psychosis (may last days), suicidal ideation, or self-harm [1][6]
- Medical toxicology consultation: Severe or atypical presentations, refractory symptoms [4]
- Social work/addiction medicine: Referral for substance use disorder treatment prior to discharge
18. Follow Up / Return Precautions
- Follow-up: PCP or addiction medicine within 3–5 days; psychiatry if psychotic symptoms persist
- Return immediately for: Recurrent agitation or confusion, chest pain, dark urine, fever, seizures, suicidal thoughts, inability to tolerate fluids
- Counseling points:
- Synthetic cathinones are highly addictive with unpredictable potency [1]
- "Not for human consumption" labeling does not mean safety
- Coingestion with alcohol or other drugs significantly increases risk of death [11]
- Psychotic symptoms may persist for days to weeks after last use [6]
- Expected course: Most mild-moderate cases resolve within 6–12 hours with supportive care; severe cases (rhabdomyolysis, renal failure, persistent psychosis) may require prolonged hospitalization [1][5]
References
1. Psychoactive "Bath Salts" Intoxication With Methylenedioxypyrovalerone. — Ross EA, Reisfield GM, Watson MC, Chronister CW, Goldberger BA. The American Journal of Medicine. 2012.
2. Synthetic Cathinones ("Bath Salts"). — Banks ML, Worst TJ, Rusyniak DE, Sprague JE. The Journal of Emergency Medicine. 2014.
3. Part 10: Adult and Pediatric Special Circumstances of Resuscitation: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. — Cao D, Arens AM, Chow SL, et al. Circulation. 2025.
4. The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder. — Journal of Addiction Medicine. 2024.
5. Bath Salts Intoxication: A Case Series. — Imam SF, Patel H, Mahmoud M, et al. The Journal of Emergency Medicine. 2013.
6. Clinical and Pharmacological Aspects of Bath Salt Use: A Review of the Literature and Case Reports. — Miotto K, Striebel J, Cho AK, Wang C. Drug and Alcohol Dependence. 2013.
7. 2023 American Heart Association Focused Update on the Management of Patients With Cardiac Arrest or Life-Threatening Toxicity Due to Poisoning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. — Lavonas EJ, Akpunonu PD, Arens AM, et al. Circulation. 2023.
8. Management of Stimulant Use Disorder. — Steven Batki MD, Daniel Ciccarone MD MPH, Scott E. Hadland MD MPH, et al American Academy of Addiction Psychiatry (2023). 2023.
9. Diagnostic and Statistical Manual of Mental Disorders. — Dilip V. Jeste, Jeffrey A. Lieberman, David Fassler, et al American Psychiatric Association (2022). 2022.
10. Critical Illness Secondary to Synthetic Cannabinoid Ingestion. — Kourouni I, Mourad B, Khouli H, Shapiro JM, Mathew JP. JAMA Network Open. 2020.
11. Toxicological Analysis of Intoxications With Synthetic Cathinones. — Pieprzyca E, Skowronek R, Czekaj P. Journal of Analytical Toxicology. 2022.
12. The New Designer Drug Wave: A Clinical, Toxicological, and Legal Analysis. — Abbott R, Smith DE. Journal of Psychoactive Drugs. 2015.
13. "Bath Salts" Intoxication: A New Recreational Drug That Presents With a Familiar Toxidrome. — Hall C, Heyd C, Butler C, Yarema M. Cjem. 2014.